SCHEMBL414333

SCHEMBL414333

O=C(O)[C@H](Cc1ccccc1)N[N+](=O)[O-].O=C(O)[C@H](Cc1ccccc1)N[N+](=O)[O-]

nearest known ligand 0.54

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
CPA1 P15085 6/20 0.54
MME P08473 2/20 0.51
MMP2 P08253 4/20 0.51
MMP9 P14780 3/20 0.51
ADAMTS4 O75173 1/20 0.51
NPSR1 Q6W5P4 1/20 0.50
NAALAD2 Q9Y3Q0 1/20 0.49
CYP1A2 P05177 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL93588 1.00 CPA1 (0.54) CPA1MMEMMP2MMP9ADAMTS4
SCHEMBL28308525 1.00 CPA1 (0.54) CPA1MMEMMP2MMP9ADAMTS4
SCHEMBL93589 1.00 CPA1 (0.54) CPA1MMEMMP2MMP9ADAMTS4
Hydrochloric Acid SCHEMBL1422098 0.98 CPA1 (0.53) CPA1MMEMMP2MMP9ADAMTS4
Water SCHEMBL7180276 0.98 CPA1 (0.53) CPA1MMEMMP2MMP9ADAMTS4
Water SCHEMBL28101244 0.98 CPA1 (0.53) CPA1MMEMMP2MMP9ADAMTS4
Alanine SCHEMBL28256330 0.91 CTSL (0.47) CPA1MMEMMP2MMP9L3MBTL1
SCHEMBL38173 0.87 FOLH1 (0.51) CPA1MMENAALAD2L3MBTL1
SCHEMBL38174 0.87 FOLH1 (0.51) CPA1MMENAALAD2L3MBTL1
Ethyl Acetate SCHEMBL8046018 0.86 CTSL (0.47) CPA1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210030918-A1 COATING OF FIBERS WITH DIPEPTIDE NANOSTRUCTURES USING ULTRASONIC CAVITATION RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2021-02-04 US claimed
EP-2089418-B1 FORMATION OF ORGANIC NANOSTRUCTURE ARRAY UNIV RAMOT (IL) 2016-11-09 EP claimed
EP-2961433-A1 PEPTIDE-BASED HYDROGEL PARTICLES AND USES THEREOF Ramot at Tel-Aviv University Ltd. (IL) 2016-01-06 EP claimed
US-9074095-B2 Malleable hydrogel hybrids made of self-assembled peptides and biocompatible polymers and uses thereof TECHNOLOGY INNOVATION MOMENTUM FUND (ISRAEL) LIMITED PARTNERSHIP (IL) 2015-07-07 US claimed
WO-2014132262-A1 PEPTIDE-BASED HYDROGEL PARTICLES AND USES THEREOF RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2014-09-04 WO claimed
EP-2575909-A1 MALLEABLE HYDROGEL HYBRIDS MADE OF SELF-ASSEMBLED PEPTIDES AND BIOCOMPATIBLE POLYMERS AND USES THEREOF Ramot at Tel Aviv University, Ltd. (IL) 2013-04-10 EP claimed
US-20130079421-A1 MALLEABLE HYDROGEL HYBRIDS MADE OF SELF-ASSEMBLED PEPTIDES AND BIOCOMPATIBLE POLYMERS AND USES THEREOF RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2013-03-28 US claimed
WO-2011151832-A1 MALLEABLE HYDROGEL HYBRIDS MADE OF SELF-ASSEMBLED PEPTIDES AND BIOCOMPATIBLE POLYMERS AND USES THEREOF RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2011-12-08 WO claimed
US-20090175785-A1 Self-Assembled Fmoc-Ff Hydrogels RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) 2009-07-09 US claimed
EP-1973928-A2 SELF-ASSEMBLED FMOC-FF HYDROGELS Ramot at Tel-Aviv University Ltd. (IL) 2008-10-01 EP claimed
WO-2007043048-A2 SELF-ASSEMBLED FMOC-FF HYDROGELS RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) 2007-04-19 WO claimed
US-20240167062-A1 HYDROGEL SYSTEM FOR CONTROLLING OXYGEN CONCENTRATION RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2024-05-23 US disclosed
WO-2023166513-A1 PEPTIDE-BASED BIOINK COMPOSITIONS RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2023-09-07 WO disclosed
WO-2023135601-A1 PEPTIDE-CONTAINING HYBRID HYDROGEL FOR BONE REGENERATION RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2023-07-20 WO disclosed
US-20210030918-A1 COATING OF FIBERS WITH DIPEPTIDE NANOSTRUCTURES USING ULTRASONIC CAVITATION RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2021-02-04 US disclosed
US-20090175785-A1 Self-Assembled Fmoc-Ff Hydrogels RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) 2009-07-09 US disclosed
WO-2009034566-A1 VAPOR DEPOSITION OF BIOMOLECULES RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) 2009-03-19 WO disclosed
EP-1973928-A2 SELF-ASSEMBLED FMOC-FF HYDROGELS Ramot at Tel-Aviv University Ltd. (IL) 2008-10-01 EP disclosed
US-20070138007-A1 Peptide nanostructure-coated electrodes RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) 2007-06-21 US disclosed
WO-2007043048-A2 SELF-ASSEMBLED FMOC-FF HYDROGELS RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) 2007-04-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240167062-A1 HYDROGEL SYSTEM FOR CONTROLLING OXYGEN CONCENTRATION HIF1A, HAO2, EGLN2 CPA1 1115/4885MME 3813/4885MMP2 1719/4885
US-20210030918-A1 COATING OF FIBERS WITH DIPEPTIDE NANOSTRUCTURES USING ULTRASONIC CAVITATION VIP, NPPA, IAPP CPA1 262/4885MME 495/4885MMP2 217/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.